FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q60609649> ?p ?o ?g. }

• Q60609649 description "artikull shkencor i botuar më 01 janar 1994" @default.
• Q60609649 description "artículu científicu espublizáu en xineru de 1994" @default.
• Q60609649 description "im Jahr 1994 veröffentlichter wissenschaftlicher Artikel" @default.
• Q60609649 description "scientific article published on 01 January 1994" @default.
• Q60609649 description "wetenschappelijk artikel" @default.
• Q60609649 description "наукова стаття, опублікована в 1994" @default.
• Q60609649 name "The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status" @default.
• Q60609649 name "The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status" @default.
• Q60609649 name "The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status" @default.
• Q60609649 type Item @default.
• Q60609649 label "The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status" @default.
• Q60609649 label "The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status" @default.
• Q60609649 label "The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status" @default.
• Q60609649 prefLabel "The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status" @default.
• Q60609649 prefLabel "The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status" @default.
• Q60609649 prefLabel "The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status" @default.
• Q60609649 P1433 Q60609649-B5C71977-1C7D-489A-B8CD-3E7CDFB78174 @default.
• Q60609649 P1476 Q60609649-669DFC24-F111-4552-9D0C-975FA29CE032 @default.
• Q60609649 P2093 Q60609649-3F9384B7-8A60-457D-80BD-408FECB35165 @default.
• Q60609649 P2093 Q60609649-DE7BF95B-030F-40C6-A249-3DD311984302 @default.
• Q60609649 P2093 Q60609649-E059BF08-3C22-4DC6-B46B-2637E816F8A0 @default.
• Q60609649 P2093 Q60609649-F3B4ED5D-9029-463E-9F08-0E6337BF66E8 @default.
• Q60609649 P2860 Q60609649-022E627B-7AD7-48E0-8D26-09B656FDEA1A @default.
• Q60609649 P2860 Q60609649-0264B76A-20B1-47F0-BAD5-638D013DC4BA @default.
• Q60609649 P2860 Q60609649-068AC80D-13DC-404F-ACA8-E3F4A40DEE3A @default.
• Q60609649 P2860 Q60609649-0DEA5FBA-D747-4FDA-92CE-3F4D4FBD83BC @default.
• Q60609649 P2860 Q60609649-169C42A4-1D19-4B56-BAF3-26A65B0A56A5 @default.
• Q60609649 P2860 Q60609649-1923B382-CD9A-44F0-BEC5-11A5DEA29407 @default.
• Q60609649 P2860 Q60609649-1F35B46C-6D34-47DF-B6FD-F2CB6765FBEA @default.
• Q60609649 P2860 Q60609649-1F9B8A7F-5322-424E-806D-5C5CF82F8B31 @default.
• Q60609649 P2860 Q60609649-2CC6B564-6155-4399-BEE8-99224130E22A @default.
• Q60609649 P2860 Q60609649-32B1BF2A-EF4A-434A-9EE4-934BF1A2DCC0 @default.
• Q60609649 P2860 Q60609649-3C089DE0-B0ED-496A-85F9-49F3C9470DCD @default.
• Q60609649 P2860 Q60609649-3F2166CF-CC86-450E-9603-DE8E1F9ED033 @default.
• Q60609649 P2860 Q60609649-4592C424-A08C-4D10-A358-0E757207EBA5 @default.
• Q60609649 P2860 Q60609649-4DDBA0EF-AE41-4DAB-AC03-FFC01AFAD0A9 @default.
• Q60609649 P2860 Q60609649-50B732C1-F5E5-45BE-B9B5-FC1EF38FA076 @default.
• Q60609649 P2860 Q60609649-5208C615-5C83-4338-933A-D3381FF2EB98 @default.
• Q60609649 P2860 Q60609649-5A7F4D92-DFB2-4919-9749-04D2026FF1D7 @default.
• Q60609649 P2860 Q60609649-61CE3AA5-B522-42BD-B3BF-2FD234CFD369 @default.
• Q60609649 P2860 Q60609649-65241C3C-8990-4AD3-9F65-0EB13DC91197 @default.
• Q60609649 P2860 Q60609649-800AAFD1-3092-4B3C-B71A-E52FE4D16758 @default.
• Q60609649 P2860 Q60609649-84008417-5F1F-4BD7-BAAA-5FEADF41787D @default.
• Q60609649 P2860 Q60609649-849AB86C-9D2A-46AF-AC95-58B94E146610 @default.
• Q60609649 P2860 Q60609649-8A80C344-77DC-4894-BC64-94566B878165 @default.
• Q60609649 P2860 Q60609649-95F1159B-2392-4A10-9206-7EE781EA6196 @default.
• Q60609649 P2860 Q60609649-97E7D63B-EB9A-423B-A99F-42E0A4DE60C7 @default.
• Q60609649 P2860 Q60609649-9A1F008C-C0CF-49AD-BE97-88193039810C @default.
• Q60609649 P2860 Q60609649-A62E5D0B-AF4D-483E-ACF2-DD0A115BC422 @default.
• Q60609649 P2860 Q60609649-AD5BA791-CFDB-466E-8DCA-760BCBEC0871 @default.
• Q60609649 P2860 Q60609649-B741B68D-75CE-476A-B448-90EED5CBA182 @default.
• Q60609649 P2860 Q60609649-C49EE708-C2FE-467A-BFB5-AFC8A14C1078 @default.
• Q60609649 P2860 Q60609649-CC1F58F3-7B94-4C9B-9F27-5D5D08B05893 @default.
• Q60609649 P2860 Q60609649-CD719E82-5869-45E0-B5B9-FBED03690C9B @default.
• Q60609649 P2860 Q60609649-DCA57DAD-3032-492D-BD38-B5FAABEE8CFA @default.
• Q60609649 P2860 Q60609649-F12AF850-B912-4C95-A0CD-11847AFDBE55 @default.
• Q60609649 P2860 Q60609649-F79C4D07-B4D8-46E2-B5EB-98C49978F5B2 @default.
• Q60609649 P2888 Q60609649-423DADA8-B144-4169-AD0E-519D861C7DCB @default.
• Q60609649 P304 Q60609649-95F71D23-B003-4657-9C14-C4C6C3611A3E @default.
• Q60609649 P31 Q60609649-FEAD4A08-370D-4C5F-B233-69A0E6566EC5 @default.
• Q60609649 P356 Q60609649-4EB0F3F1-05C8-4E07-90CC-3AE8C93A09EF @default.
• Q60609649 P433 Q60609649-FE765557-E569-44C7-8C89-DF4DD4D484A5 @default.
• Q60609649 P478 Q60609649-F64DCB3A-9521-4434-8541-68EFAAAEBDEF @default.
• Q60609649 P50 Q60609649-21D098DA-18B1-481A-823A-033BCA57669A @default.
• Q60609649 P50 Q60609649-4A01A68F-2ADB-4814-BEDF-887BA5E083C0 @default.
• Q60609649 P577 Q60609649-D8FCEB3B-E886-4FD4-9846-0B9F0025CEB8 @default.
• Q60609649 P698 Q60609649-665767D9-1267-418F-A005-AF8B7550BBAA @default.
• Q60609649 P921 Q60609649-3424A1AB-6D39-4A86-AD7A-17128289F541 @default.
• Q60609649 P356 BF00197392 @default.
• Q60609649 P698 7981903 @default.
• Q60609649 P1433 Q19059548 @default.
• Q60609649 P1476 "The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status" @default.
• Q60609649 P2093 "C Chiarelli" @default.
• Q60609649 P2093 "G Viale" @default.
• Q60609649 P2093 "L Laurino" @default.
• Q60609649 P2093 "M Barbareschi" @default.
• Q60609649 P2860 Q28266311 @default.
• Q60609649 P2860 Q28294137 @default.
• Q60609649 P2860 Q28306437 @default.
• Q60609649 P2860 Q29615610 @default.
• Q60609649 P2860 Q29620000 @default.
• Q60609649 P2860 Q29622924 @default.
• Q60609649 P2860 Q34559025 @default.
• Q60609649 P2860 Q35233723 @default.
• Q60609649 P2860 Q35675178 @default.
• Q60609649 P2860 Q35811930 @default.
• Q60609649 P2860 Q35832489 @default.
• Q60609649 P2860 Q35833088 @default.
• Q60609649 P2860 Q36224918 @default.
• Q60609649 P2860 Q36782441 @default.
• Q60609649 P2860 Q36895398 @default.
• Q60609649 P2860 Q37554227 @default.
• Q60609649 P2860 Q37572590 @default.
• Q60609649 P2860 Q37974995 @default.
• Q60609649 P2860 Q41735487 @default.
• Q60609649 P2860 Q41858338 @default.
• Q60609649 P2860 Q41883704 @default.
• Q60609649 P2860 Q41957968 @default.
• Q60609649 P2860 Q42457244 @default.
• Q60609649 P2860 Q42508274 @default.

• next